Literature DB >> 15712369

Liquid chromatography/electrospray tandem mass spectrometry of terpenoid lactones in Ginkgo biloba.

Yongkai Sun1, Wenkui Li, John F Fitzloff, Richard B van Breemen.   

Abstract

Ginkgo biloba (ginkgo) is one of most frequently used botanical dietary supplements. The bioactive constituents include the terpenoid lactones consisting of bilobalide and the ginkgolides A, B, C and J. A new assay based on high-performance liquid chromatography/electrospray tandem mass spectrometry (LC/MS/MS) was developed for the measurement of the terpenoid lactones in ginkgo products such as leaf powder and extracts. Initially, the MS/MS fragmentation pathways of ginkgolides were investigated to identify abundant fragment ions that might be useful for the sensitive and selective detection of ginkgolides and bilobalide during LC/MS/MS. Then, sample preparation and clean-up procedures were streamlined to maximize throughput by taking advantage of the selectivity of LC/MS/MS detection. Analyte recoveries exceeded 90%, the intra-assay and inter-assay relative standard deviations were <5%, the relative error was <8% and the limits of detection and quantification were 3.6-120 and 11-350 fmol, depending on the analyte that was injected on to the LC column. Therefore, this LC/MS/MS assay facilitated the rapid quantitative analysis of ginkgolides A, B, C and J and bilobalide in ginkgo dietary supplements with excellent recovery, reproducibity, accuracy and sensitivity. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712369      PMCID: PMC1852454          DOI: 10.1002/jms.795

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  22 in total

1.  Simultaneous determination of terpene lactones and flavonoid aglycones in Ginkgo biloba by high-performance liquid chromatography with evaporative light scattering detection.

Authors:  Wenkui Li; John F Fitzloff
Journal:  J Pharm Biomed Anal       Date:  2002-08-22       Impact factor: 3.935

2.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

Review 3.  The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).

Authors:  P F Smith; K Maclennan; C L Darlington
Journal:  J Ethnopharmacol       Date:  1996-03       Impact factor: 4.360

4.  Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts.

Authors:  P Mauri; P Simonetti; C Gardana; M Minoggio; P Morazzoni; E Bombardelli; P Pietta
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

5.  Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

Authors:  S Kanowski; W M Herrmann; K Stephan; W Wierich; R Hörr
Journal:  Pharmacopsychiatry       Date:  1996-03       Impact factor: 5.788

6.  Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.

Authors:  A Biber; E Koch
Journal:  Planta Med       Date:  1999-03       Impact factor: 3.352

7.  Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

Authors:  K Maurer; R Ihl; T Dierks; L Frölich
Journal:  J Psychiatr Res       Date:  1997 Nov-Dec       Impact factor: 4.791

8.  [Biological standardization of Ginkgo extracts].

Authors:  B Steinke; B Müller; H Wagner
Journal:  Planta Med       Date:  1993-04       Impact factor: 3.352

Review 9.  Ginkgo biloba for cerebral insufficiency.

Authors:  J Kleijnen; P Knipschild
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

10.  Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease.

Authors:  Yuan Luo
Journal:  J Alzheimers Dis       Date:  2001-08       Impact factor: 4.472

View more
  2 in total

1.  Extraction and Analysis of Terpenes/Terpenoids.

Authors:  Zuodong Jiang; Chase Kempinski; Joe Chappell
Journal:  Curr Protoc Plant Biol       Date:  2016-06-10

2.  H NMR-based metabolomics combined with HPLC-PDA-MS-SPE-NMR for investigation of standardized Ginkgo biloba preparations.

Authors:  Sara Agnolet; Jerzy W Jaroszewski; Robert Verpoorte; Dan Staerk
Journal:  Metabolomics       Date:  2010-01-06       Impact factor: 4.290

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.